Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Brinzolamide for Infantile Nystagmus Syndrome
NCT01312402Phase 4Completed
- Sponsor
- Akron Children's Hospital
- Start
- Jan 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brinzolamide in Infantile Nystagmus Syndrome (INS), sponsored by Akron Children's Hospital. Started Jan 2011; status: completed.
02
Drugs
brinzolamide
03
Conditions
Infantile Nystagmus Syndrome (INS)
Beyond the preview
Go deeper on NCT01312402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312402.